Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Methods Mol Biol ; 2118: 289-303, 2020.
Article in English | MEDLINE | ID: mdl-32152988

ABSTRACT

Nanoparticle tracking analysis (NTA) provides direct and real time visualization, sizing and counting of particulate materials between 10 nm and 1 µm in liquid suspension. The technique works on a particle by particle basis, relating the degree of movement under Brownian motion to the sphere equivalent hydrodynamic diameter particle size, allowing for high-resolution particle size distributions to be obtained within minutes. NTA has been used in studying protein complexes and protein aggregates, protein nanoparticles, metal nanoparticles, silica nanoparticles, viruses, cellular vesicles and exosomes to name just a few. Here we describe application of NTA to the analysis of model nanospheres of ~100 nm in liquid suspension, the size being representative of the middle of the NTA working range. The technique described can be adapted for use with nearly all particulate materials with sizes between approximately 10 nm and 1 µm, with appropriate adjustments to instrument settings.


Subject(s)
Nanoparticles/ultrastructure , Single Molecule Imaging/methods , Dynamic Light Scattering , Maillard Reaction , Particle Size , Suspensions
2.
PLoS One ; 10(7): e0132845, 2015.
Article in English | MEDLINE | ID: mdl-26177391

ABSTRACT

Pancreatic cancer has the highest mortality rates of all cancer types. One potential explanation for the aggressiveness of this disease is that cancer cells have been found to communicate with one another using membrane-bound vesicles known as exosomes. These exosomes carry pro-survival molecules and increase the proliferation, survival, and metastatic potential of recipient cells, suggesting that tumor-derived exosomes are powerful drivers of tumor progression. Thus, to successfully address and eradicate pancreatic cancer, it is imperative to develop therapeutic strategies that neutralize cancer cells and exosomes simultaneously. Curcumin, a turmeric root derivative, has been shown to have potent anti-cancer and anti-inflammatory effects in vitro and in vivo. Recent studies have suggested that exosomal curcumin exerts anti-inflammatory properties on recipient cells. However, curcumin's effects on exosomal pro-tumor function have yet to be determined. We hypothesize that curcumin will alter the pro-survival role of exosomes from pancreatic cancer cells toward a pro-death role, resulting in reduced cell viability of recipient pancreatic cancer cells. The main objective of this study was to determine the functional alterations of exosomes released by pancreatic cancer cells exposed to curcumin compared to exosomes from untreated pancreatic cancer cells. We demonstrate, using an in vitro cell culture model involving pancreatic adenocarcinoma cell lines PANC-1 and MIA PaCa-2, that curcumin is incorporated into exosomes isolated from curcumin-treated pancreatic cancer cells as observed by spectral studies and fluorescence microscopy. Furthermore, curcumin is delivered to recipient pancreatic cancer cells via exosomes, promoting cytotoxicity as demonstrated by Hoffman modulation contrast microscopy as well as AlamarBlue and Trypan blue exclusion assays. Collectively, these data suggest that the efficacy of curcumin may be enhanced in pancreatic cancer cells through exosomal facilitation.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Pancreatic Ductal/drug therapy , Curcumin/pharmacology , Exosomes/metabolism , Pancreatic Neoplasms/drug therapy , Cell Line, Tumor , Cell Shape/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Humans
3.
Cell Cycle ; 12(22): 3526-36, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24091630

ABSTRACT

Prostate cancer cells release atypically large extracellular vesicles (EVs), termed large oncosomes, which may play a role in the tumor microenvironment by transporting bioactive molecules across tissue spaces and through the blood stream. In this study, we applied a novel method for selective isolation of large oncosomes applicable to human platelet-poor plasma, where the presence of caveolin-1-positive large oncosomes identified patients with metastatic disease. This procedure was also used to validate results of a miRNA array performed on heterogeneous populations of EVs isolated from tumorigenic RWPE-2 prostate cells and from isogenic non-tumorigenic RWPE-1 cells. The results showed that distinct classes of miRNAs are expressed at higher levels in EVs derived from the tumorigenic cells in comparison to their non-tumorigenic counterpart. Large oncosomes enhanced migration of cancer-associated fibroblasts (CAFs), an effect that was increased by miR-1227, a miRNA abundant in large oncosomes produced by RWPE-2 cells. Our findings suggest that large oncosomes in the circulation report metastatic disease in patients with prostate cancer, and that this class of EV harbors functional molecules that may play a role in conditioning the tumor microenvironment.


Subject(s)
Caveolin 1/metabolism , Cell-Derived Microparticles/metabolism , MicroRNAs/metabolism , Prostatic Neoplasms/pathology , Cell Line, Tumor , Cell Movement , Fibroblasts/pathology , Fibroblasts/physiology , Gene Regulatory Networks , Humans , In Vitro Techniques , Male , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , RNA Transport , Tumor Microenvironment
SELECTION OF CITATIONS
SEARCH DETAIL
...